multi-omics approach to understanding pd-l1 resistance in cancer
Published 4 years ago • 522 plays • Length 1:01:13Download video MP4
Download video MP3
Similar videos
-
1:14:18
sepulveda, yang & lotan-applying a multi-omics approach to tumor biomarker discovery-case studies
-
27:57
primary and acquired resistance to cancer immunotherapy
-
2:12
cancer immunotherapy | the pd-l1 pathway
-
38:46
a multi-omic single cell and spatial atlas of breast cancer reveals stromal suppression
-
33:31
occpr webinar series: dr. sam payne – using multi-omics data to understand the cancer phenotype
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
1:33:59
revisiting pd-l1 as an immunotherapy biomarker across the cancer spectrum
-
32:06
multi-omic integration for understanding disease
-
26:28
multi-omics analysis of the response to immune checkpoint inhibitors at single cell resolution
-
32:21
monitoring tumor microenvironment immunotherapeutic impact in heterogeneous cancer: prostate cancer,
-
2:10:39
the path of tumor research in the multi-omics and ai era - 18/11/2021
-
50:03
arlene sharpe: roles of the pd-1 pathway in controlling tolerance & tumor immunity
-
39:55
new checkpoints and biomarkers
-
36:47
the status of pd-l1 testing and what is next? | presented by dr. ming tsao
-
6:56
all you need to know about pd-l1 by immunohistochemistry
-
3:43
biomarkers in nsclc: a pathologist's insight into pd-l1 and tmb
-
59:37
keynote presentation: development of rational immunotherapy combinations to overcome the immuno...
-
15:11
understanding cancer immunotherapy
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy